Results from a randomized clinical trial suggest that $10 is not enough to motivate people to return their fecal immunochemical tests for colorectal cancer screening.

Shivan J. Mehta, MD, MBA, MSHP, of the department of medicine at the Perelman School of Medicine at the University of Pennsylvania, and colleagues wrote that FIT completion remains low despite the success of tests mailed directly to patients.